Celularity Inc. Preferred Stock, Shares Outstanding
Celularity Inc. (CELU) had Preferred Stock, Shares Outstanding of 1.73 million shares as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-04-30
- 2025-12-31: Preferred Stock, Shares Outstanding 1.73M shares.
- 2025-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2025-12-31 | 1.73M shares 10-K · filed 2026-04-30 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-29 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-08-29 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-04-30 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-12-06 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-11-07 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-10-16 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-05-08 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-01-03 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-22 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-07-30 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-12 |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |